First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan
The Progeria Research Foundation Marks Significant Achievement as Zokinvy™ (lonafarnib) Receives Japanese Approval for the Treatment of Progeria and Processing-Deficient Progeroid Laminopathies PEABODY, Mass., Jan. 20, 2024 /PRNewswire/ — The Progeria Research Foundation (PRF) today announced a new milestone with the approval of Zokinvy™ (lonafarnib) by the Japanese Ministry of Health, Labor and Welfare (MHLW), for … Read more